Asthma
RecruitingA study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma
- Disease:Asthma
- Substances:–
Poland- Participants:18–64 years · 65+ years
- Sponsor:Kymera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Poland7 clinical trials in Zawadzkie, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on chronic obstructive pulmonary disease (COPD) evaluating new fixed-dose combination therapies to improve lung function and breathing capacity in patients.
Studies aim to enhance treatment options for patients with moderate to severe COPD symptoms.
Comprehensive trials investigating new treatments for severe asthma, including studies of rescue medications and long-term management options for patients with eosinophilic phenotype.
Research focuses on developing more effective therapeutic approaches for different asthma severities.
Groundbreaking studies examining treatments for chronic rhinosinusitis with nasal polyposis, evaluating new biological therapies and their impact on symptom improvement.
Trials aim to advance treatment options for patients with persistent nasal and sinus symptoms.
Innovative investigations into refractory and unexplained chronic cough, studying novel therapeutic approaches for symptom management and long-term relief.
Research focuses on developing solutions for patients with persistent cough symptoms resistant to standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.